Definitive Contract 75N92022C00006
Award Date
11/8/21
Potential Completion Date
12/31/22
Potential Value
$1.2M
Federal Agency
National Heart Lung and Blood Institute
Awardee
Mirimus, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Brooklyn, NY 11226, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Purchase Order to Mirimus, Inc., a self-certified small disadvantaged business, for $17,147.50. The contract is for the provision of custom vector expressions. Mirimus, Inc. specializes in engineering mouse models with reversible gene silencing capabilities using RNA interference and has provided scientific supplies, reagents, custom vector...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Mirimus, Inc., a self-certified small disadvantaged business. The $17,147.50 contract is for the delivery of custom vector expressions to support biomedical research. Mirimus is a provider of customized mouse models and reagents, specializing in reversible gene silencing technologies. In addition to...
The National Institutes of Health awarded a $50.7 million firm fixed price modification to MicroGEM US Inc. under the RADX Tech Program. The modification extends an existing contract to maintain MicroGEM's production of 160,000 saliva-based, high-performing RT-PCR point-of-care cartridges and 1,000 portable devices per day for COVID-19 testing. The 25-minute tests and devices are non-invasive and portable. Funding comes from the Department of Health and Human Services National Institutes of...
The Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute awarded a $22.57 million firm fixed price definitive contract to Flambeau Diagnostics LLC of Monona, Wisconsin. The contract is for the delivery of RADX TECH 2375 point-of-need, saliva-based COVID-19 testing platforms over a twenty-month period ending in March 2023. No subcontractors or set aside designations were indicated. The award supports the NIH's ongoing efforts to...
Minute Molecular Diagnostics, Inc. was awarded a definitive, firm fixed price contract valued at seventeen million, five hundred ninety thousand dollars by the Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute. The contract is for the RADX TECH PROJECT 2200 to develop a high-throughput, fast-turnaround, field-deployable COVID-19 molecular diagnostic system. Work will be performed in Evanston, Illinois with a period of performance...
This is a $6,250,000.00 firm fixed-price definitive contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits and medical testing technologies. The contract is for the Rapid Acceleration of Diagnostics (RADx) Tech Project #6139, which involves the supply of Meridian Bioscience's RevogeneⓇ SARS-CoV-2 assay. This diagnostic test is being procured to support the...
This federal contract award, valued at $95,090.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The award, which did not have a set-aside designation, was made to Neoteryx, LLC, a limited liability company that specializes in scientific specimen collection and microsampling devices. The contract was for the provision of "20UL MITRA CLAMSHELL (4-SAMPLER) | COLLECTION KIT FOR COVID19...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services, to Neoteryx, LLC, a for-profit limited liability company that manufactures scientific specimen collection and microsampling devices. The contract, valued at $97,975.00, is for the delivery of MITRA clamshell collection kits to support COVID-19 testing and research. The contract has a performance period ending on...
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services National Institutes of Health (NIH) Clinical Center to Miravista Diagnostics LLC, a for-profit limited liability company that manufactures goods and provides clinical laboratory testing services. The $43,000.00 contract is for fungal testing services and has a completion date of March 21, 2025. Miravista Diagnostics has experience providing specialized laboratory services, including microbiology...
Mammoth Biosciences Inc., doing business as Mammoth Diagnostics, has been awarded a $20.8 million firm fixed price definitive contract by the National Institutes of Health's National Heart, Lung, and Blood Institute to support the RADX Tech program. Under this contract, Mammoth Diagnostics will utilize its CRISPR-based Detectr platform to develop assays for the detection of SARS-CoV-2, the virus that causes COVID-19. The work will be performed in South San Francisco, California over an...